Sushilkumar Satish Gupta, MD
Pulmonary Disease · Ithaca, NYNPI 1750799722
Payments from drug & device makers
Across 19 payments — averaging $137.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Covidien LP$2K
- Boehringer Ingelheim$125
- Mallinckrodt Hospital Products Inc.$118
- Astellas Pharma US Inc$77
- AstraZeneca$48
- Viatris Specialty LLC$30
- plus $62 from 3 others
What the payments were for
- Travel & lodging$1,64863%
- Food & beverage$88634%
- Education$773%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Covidien LP | 10 | $2,151 |
| Boehringer Ingelheim | 1 | $125 |
| Mallinckrodt Hospital Products Inc. | 1 | $118 |
| Astellas Pharma US Inc | 1 | $77 |
| AstraZeneca | 2 | $48 |
| Viatris Specialty LLC | 1 | $30 |
| GSK | 1 | $29 |
| Shionogi Inc | 1 | $20 |
| Philips North America LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- superDimension$1,704
- OFEV$125
- ACTHAR$118
How this compares
$2,611 in reported general payments places this provider in the 60th percentile of 1,115 pulmonary disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 11 | $109 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Ithaca
- Linda RogersNew York$7.1M
- Maria PadillaNew York$3.6M
- R WhiteRochester$3.1M
- Juan WisniveskyNew York$3M
- Bushra MinaNew York$2.5M
- Robert KanerNew York$2.3M
- Negin HajizadehGreenport$2M
- Doreen Addrizzo-HarrisNew York$1.9M
- Sherif El BayadiSyracuse$1.9M
- Daniel LachantRochester$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.